#1 Clinical Trials Search in Europe

Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

↓

Matched clinical trials

  • Study of ultevursen treatment in patients with retinitis pigmentosa caused by mutations in USH2A gene exon 13

    Recruiting

    2 1
    Investigated drugs:
    Belgium Denmark France Germany Italy The Netherlands

  • Study of GS030 gene therapy safety and tolerability in patients with Retinitis Pigmentosa

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Long-term Safety and Efficacy Study of Gene Therapy for Choroideremia and X-Linked Retinitis Pigmentosa Using AAV2-REP1 and AAV8-RPGR in Previously Treated Patients

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany

  • Study on the Safety and Effects of ISTEM-01 and Mycophenolate Mofetil for Patients with Retinitis Pigmentosa Due to a Genetic Mutation

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on the Effectiveness and Safety of Ultevursen for Patients with Retinitis Pigmentosa Due to USH2A Gene Mutations

    Not yet recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy The Netherlands

  • Study on the Safety and Effectiveness of AGTC-501 for Men with X-linked Retinitis Pigmentosa

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study of AAVB-081 and Prednisolone for Patients with Usher Syndrome Type 1B Retinitis Pigmentosa

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study of HORA-PDE6B’s Safety in Retinitis Pigmentosa Patients with PDE6B Gene Mutations

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Long-Term Safety and Efficacy Study of Botaretigene Sparoparvovec for Patients with X-Linked Retinitis Pigmentosa

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Belgium Denmark France Italy The Netherlands Spain

  • Study on the Safety and Effects of CPK850 Gene Therapy for Patients with Retinitis Pigmentosa Due to RLBP1 Gene Mutations

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden